Edison Pharmaceuticals Inc — Form D
Edison Pharmaceuticals Inc of MOUNTAIN VIEW, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-25. The offering totals $10.0M, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-08-25
- Form: D
- Accession: 0001104659-10-045850
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $10.0M
- Amount sold: $250K
- Remaining: $9.8M
- Investors: 1
- Date of first sale: 2010-08-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-146897
Issuer
- Name: Edison Pharmaceuticals Inc
- CIK: 0001346136
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: 350 NO. BERNARDO AVE., MOUNTAIN VIEW, CA, 94043
- Phone: 650-641-9200
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Paul Avery | Director | Tampa, FL |
| Martin Thoolen | Executive Officer | Mountain View, CA |
| Taro Inaba | Director | TOKYO, M0 |
| Isaac Cheng | Director | Portland, ME |
| Carl Berg | Director | Cupertino, CA |
| Forrest Sawyer | Director | Mountain View, CA |
| Guy Miller | Director | Mountain View, CA |
| Guy Miller | Executive Officer | Mountain View, CA |
| Martin E Thoolen | Director | Mountain View, CA |
| Forrest E Sawyer | Director | Mountain View, CA |
| Carl E Berg | Director | Orem, UT |
| Martine Thoolen | Executive Officer | Mountain View, CA |
| Keith Tsukimura | Executive Officer | Mountain View, CA |
Other filings by this issuer (5)
More